Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical Study of Non-inferiority Between Aesculus Hippocastanum, Polygonum Acre, Smilax Pepyracea, Rutin Versus Diosmin and Hesperidin in Chronic Venous Insufficiency
NCT06579482Phase 4Completed
- Sponsor
- Fundação Educacional Serra dos Órgãos
- Start
- Nov 2024
- Primary completion
- May 2025
- Modality
- Transdermal Patches, Nucleic Acid-Directed Small Molecules, Hydrogel Systems
- Countries
- 1
01
Overview
A Phase 4 trial of Horse chestnut seed extract, polygonum acre, smilax papyracea, rutin in chronic venous insufficiency (CVI), sponsored by Fundação Educacional Serra dos Órgãos. Started Nov 2024; status: completed.
02
Drugs
Horse chestnut seed extractpolygonum acresmilax papyracearutin
03
Conditions
chronic venous insufficiency (CVI)
Beyond the preview
Go deeper on NCT06579482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06579482.